Skip to content

MINDER Health Management Study for Dementia: A study to refine and evaluate technologies in the home to monitor and manage the health of people with dementia

MINDER Health Management Study for Dementia - Phase 1.5

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN71000991
Enrollment
230
Registered
2018-10-10
Start date
2018-08-20
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia Mental and Behavioural Disorders Dementia

Interventions

This study uses the TIHM for Dementia System of Care, an Internet of Things (IoT) health monitoring and integrated management system. This system gathers information about the person with dementia thr

Sponsors

Surrey and Borders Partnership NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Person with dementia: 1. Male or female 50 years of age and older at baseline with a confirmed diagnosis of dementia (any type) by specialist assessment 2. Willing and able to provide informed consent 3. Standard MMSE score at baseline interview over 12 4. Living in the community 5. Receiving 10 or more hours per week of home care 6. Have a live in or nominated carer 7. Have sufficient functional English to allow completion of the assessment instruments 8. If on anti-dementia medication (cholinesterase inhibitors and/or memantine), on a stable dose for three months prior to recruitment Carers of people with dementia: 1. Willing and able to provide informed consent 2. Single nominated informal carer (relative/friend) who has known the person with dementia for at least 6 months and is able to attend research assessments with the person with dementia 3. Have sufficient functional English to allow completion of the assessment instruments 4. Aged 18 or over Professional (including health care, technology professionals) sample: 1. Aged 18 or over 2. Involved in the delivery of care/data monitoring/technical delivery of IoT intervention of people with dementia 3. Willing to provide informed consent

Exclusion criteria

Exclusion criteria: People with dementia: 1. In a residential care home 2. Receipt of any investigational drug within 30 days prior to consenting 3. People with unstable mental state including severe depression, severe psychosis, agitation and anxiety whom their medication was change over the last 4 weeks 4. People with severe sensory impairment 5. Unable to communicate verbally 6. Currently have active suicidal ideas 7. People who require regular elective hospital admission for their physical health monitoring 8. People who are receiving treatment for terminal illness Carers of people with dementia: 1. Unable to communicate verbally Professionals: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
The composition of an optimised TIHM for Dementia System of Care solution based on: 1. Direct cost: Data on service use and patterns of unpaid care and support provided by families and friends will be recorded by a modified version of the Client Service Receipt Inventory (CSRI). Costs will be attributed to service use using NHS reference costs and unit costs from the Personal Social Services Research Unit (PSSRU, www.pssru.ac.uk). This will be assessed at the baseline and after 3 and 6 months 2. Service-use data, collected via a modified CSRI at the baseline and after 3 and 6 months 3. System performance, captured in real-time through data captured by the system itself on alerts related to technical performance 4. User-acceptability, assessed using an investigator designed tool developed based on the TAM at the baseline and after 3 and 6 months

Secondary

MeasureTime frame
The following are assessed at the baseline and after 3 and 6 months: 1. Incidence of A&E attendance, assessed using a modified version of the Client Service Receipt Inventory (CSRI) 2. Duration of hospital stay, assessed using a modified version of the Client Service Receipt Inventory (CSRI) 3. Incidence and severity of neuropsychiatric symptoms experienced by the person with dementia (PwD), assessed using the Neuropsychiatric Inventory–Questionnaire (NPI) 4. Incidence of urinary tract infections, agitation and falls experience by the PwD, assessed using a modified version of the Client Service Receipt Inventory (CSRI) 5. Health Related Quality of Life (HR-QoL) of the PwD, assessed using: 5.1. DemQoL 5.2. EQ-5D-5L 6. HR-QoL of carers, assessed using the EQ-5D-5L 7. Carer burden, assessed using the Zarit Burden Interview 8. Technology acceptance, assessed using an investigator-developed tool

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026